Cisplatin activates survival signals in UM-SCC-23 squamous cell carcinoma and these signal pathways are amplified in cisplatin-resistant squamous cell carcinoma

Oncology Reports

Volumn 11, Issue 2, 2004, Pages 375-379

  Aoki, Kenta ^a   Ogawa, Tetsuya ^b   Ito, Yatsuji ^a   Nakashima, Shigeru ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Akt; Cisplatin; Drug resistance; ERK; Ras; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL SURVIVAL; DRUG EFFECT; DRUG RESISTANCE; HEAD AND NECK TUMOR; HUMAN; METABOLISM; ONCOGENE RAS; PHYSIOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENES, RAS; HEAD AND NECK NEOPLASMS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 3242806803     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.2.375     Document Type: Article

References (25)

1. Segal-Bredirdjian E and Jacquemin-Sablon A: Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process. Exp Cell Res 218: 201-212, 1995.
2. Henkels K and Turchi JJ: Induction of apoptosis in cisplatinsensitive and -resistant human ovarian cancer cell lines. Cancer Res 57: 4488-4492, 1997. (Pubitemid 27441050)
3. Henkels K and Turchi JJ: Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independndent pathways in cisplatin-sensitive and -resistant human ovarian cancer cell lines. Cancer Res 59: 3077-3083, 1999. (Pubitemid 29316005)
4. Noda S, Yoshimura S, Sawada M, Naganawa T, Iwama T, Nakashima S and Sakai N: Role of ceramide during cisplatin-induced apoptosis in C6 glioma cells. I Neurooncol 52: 11-21, 2001. (Pubitemid 32544656)
5. Kuwahara D, Tsutsumi K, Oyake D, Ohta T, Nishikawa H and Koizuka I: Inhibition of caspase-9 activity and Apaf-1 expression in cisplatin-resistant head and neck squamous cell carcinoma cells. Auris Nasus Larynx 30: S85-S88, 2003. (Pubitemid 36132344)
6. Dempke W, Voigt W, Grothey A, Hill BT and Schmoll HJ: Cisplatin resistance and oncogenes - a review. Anticancer Drugs 11: 225-236, 2000. (Pubitemid 30416950)
7. Datta SR, Brunet A and Greenberg ME: Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927, 1999.
8. Wang HG, Rapp UR and Reed JC: Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87: 629-638, 1996. (Pubitemid 26386937)
9. Erhardt P, Schremser EJ and Cooper GM: B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/ERK pathway. Mol Cell Biol 19: 5308-5315, 1999. (Pubitemid 29339890)
10. Khwaja A, Rodrigues-Vicana P, Wennstrom S, Warne PH and Downward J: Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16: 2783-2793, 1997. (Pubitemid 27226215)
11. Marais R, Light Y, Paterson HF and Marshall CJ: Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J 14: 3136-3145, 1995.
12. Osawa Y, Banno Y, Nagaki M, Brenner DA, Naiki T, Nozawa Y, Nakashima S and Moriwaki H: TNF-α-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J Immunol 167: 173-180, 2001. (Pubitemid 32567775)
13. Von Gise A, Lorenz P, Wellbrock C, Hemmings B, Berberrich-Siebelt F, Rapp UR and Troppmair J: Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3- kinase dependent signals. Mol Cell Biol 21: 2324-2336, 2001. (Pubitemid 32222086)
14. Jin W, Wu L, Liang K, Liu B, Lu Y and Fan Z: Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells. Br J Cancer 89: 185-191, 2003. (Pubitemid 36897956)
15. Shelton JG, Steelman LS, Lee JT, Knapp SL, Blalock WL, Moye PW, Franklin RA, Pohnert SC, Mirza AM, McMahon M and McCubrey JA: Effect of RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokinedependence and prevention of apoptosis in hematopoietic cells. Oncogene 22: 2478-2492, 2003. (Pubitemid 36560731)
16. Hetman M, Kanning K, Cavanaugh JE and Xia Z: Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 274: 22569-22580, 1999.
17. Xue L, Murray JH and Tolkovsky AM: The Ras/phosphatidylinositol 3-kinases and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons. J Biol Chem 275: 8817-8824, 2000. (Pubitemid 30180237)
18. Yao R and Cooper GM: Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267: 2003-2006, 1995.
19. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD and Glass DJ: Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286: 1738-1741, 1999. (Pubitemid 129515881)
20. Zimmermann S and Moelling K: Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286: 1741-1744, 1999. (Pubitemid 129515882)
21. Guan K-L, Figueroa C, Brtva TR, Zhu T, Taylor J, Barber TD and Vojtek AB: Negative regulation of the serine/threonine kinase B-Raf by Akt. J Biol Chem 275: 27354-27359, 2000.
22. Moelling K, Schad K, Bosse M, Zimmermann S and Schweneker M: Regulation of Raf-Akt cross-talk. J Biol Chem 277: 31099-1106, 2002. (Pubitemid 34970815)
23. Majewski M, Niebrowska-Shorska M, Salomoni P, Slupianek A, Reiss K, Trotta R, Calabretta B and Skorski T: Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. Cancer Res 59: 2815-2819, 1999. (Pubitemid 29283115)
24. York RD, Molliver DC, Grewal SS, Stenberg PE, McClskey EW and Stork PIS: Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Mol Cell Biol 20: 8069-8083, 2000.
25. Gelfanov VM, Burgess GS, Litz-Iackson S, King AJ, Marshall MS, Nakshatri H and Boswell HS: Transformation of interleukin-3-dependent cells without participation of Stat5/bcl-xL: cooperation of akt with raf/erk leads to p65 nuclear factor κB-mediated antiapoptosis involving C-IAP2. Blood 98: 2508-2517, 2003.